Basecamp Research Integrates EDEN Models into Claude Science for Antibiotic and Vaccine Design

Basecamp Research has made its EDEN antibiotic and vaccine design models available through Anthropic's Claude Science platform, announced in a press release. Researchers can now use Claude’s conversational interface to design antibiotics and identify vaccine targets within minutes.

The integration combines Claude’s reasoning capabilities with EDEN’s biological design models, enabling scientists to move directly from target selection to a shortlist of therapeutic candidates. The functionality is accessible through Claude.ai, Claude Desktop, Claude Mobile, Claude Code, Cowork, and Claude Science.

Basecamp Research collaborated with the University of Pennsylvania’s Machine Biology Group to validate EDEN’s antibiotic design performance. Laboratory tests showed that 97 percent of EDEN-generated antibiotic peptides were active against World Health Organisation priority pathogens. One candidate, EDEN-7, demonstrated efficacy in mice infected with multidrug-resistant Acinetobacter baumannii comparable to existing last-line antibiotics.

EDEN’s vaccine design model can identify proteins most likely to trigger protective immune responses, reducing weeks of laboratory work to a single interaction. The models are trained on BaseData, the company’s extensive biological dataset built from over 200 global field expeditions. This dataset contains over 10 billion genes, forming the foundation for the Trillion Gene Atlas project in partnership with Anthropic, NVIDIA, PacBio, and Ultima Genomics.